CellMEAT is a series a startup based in South Korea. 1 investor tracked.
CellMEAT is a company founded in 2022 headquartered in South Korea. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
CellMEAT is a biotech company developing cultured meat using plant-based biomass scaffolding and serum-free culture media.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.